Arca
Skip to content

Waveguard (Tm) Eeg Cap

Electrode, Cutaneous. 510(k) K110223, from Eemagine Medical Imaging Solutions GmbH (Naples, FL). Product code GXY, class 2.

As of Nov 16, 2026, K110223 is an FDA 510(k) held by Eemagine Medical Imaging Solutions GmbH, substantially equivalent on Jun 29, 2011 after 155 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Jun 29, 2011
  • Review time: 155 days
  • Recalls: 0
  • Cited as a predicate by: 4 devices

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

This is an EEG electrode set intended for routine clinical settings where rapid placement of large number or EEG electrodes is desired.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a Predicate

4 later 510(k) summaries name this device as a predicate

Other GXY Clearances

The newest 510(k)s for the same product code; their median review was 135 days; see every GXY device

Record

Type
Traditional
Received
Jan 25, 2011
Review panel
Neurology
Regulation
21 CFR 882.1320

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.